Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer

AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer

Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma

COVID-19 and breast cancer: How should we treat our patients?

Reducing damage to swallowing muscles during radiotherapy for head and neck cancers

Updated results from KEYNOTE-426 for metastatic kidney cancer

HCRN GU16-260: Nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with advanced renal cell carcinoma

Comment: JAVELIN-100 for metastatic urothelial cancer

3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck

Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer

METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer